Regarding the patients with IPMN, the rates of overall survival were not significantly different between high and low levels of FDG‐PET (P = .109), GLUT1 (P = .297), and pS6 (P = .326), respectively (Figure 4). This evidence concerns the gene TAS2R63P and pancreatic intraductal papillary-mucinous neoplasm.